1. Home
  2. LUMN vs GRFS Comparison

LUMN vs GRFS Comparison

Compare LUMN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumen Technologies Inc.

LUMN

Lumen Technologies Inc.

N/A

Current Price

$3.93

Market Cap

6.2B

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.20

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LUMN
GRFS
Founded
1968
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.2B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
LUMN
GRFS
Price
$3.93
$8.20
Analyst Decision
Hold
Buy
Analyst Count
10
2
Target Price
$5.92
★ $10.37
AVG Volume (30 Days)
★ 14.7M
721.2K
Earning Date
11-04-2026
07-28-2022
Dividend Yield
N/A
★ 3.35%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $12,402,000,000.00
N/A
Revenue This Year
N/A
$2.18
Revenue Next Year
N/A
$6.15
P/E Ratio
★ N/A
$18.67
Revenue Growth
N/A
★ N/A
52 Week Low
$3.84
$6.96
52 Week High
$11.30
$9.77

Technical Indicators

Market Signals
Indicator
LUMN
GRFS
Relative Strength Index (RSI) 36.41 47.67
Support Level $3.84 $7.52
Resistance Level $6.87 $8.36
Average True Range (ATR) 0.38 0.23
MACD 0.01 -0.07
Stochastic Oscillator 7.05 11.39

Price Performance

Historical Comparison
LUMN
GRFS

About LUMN Lumen Technologies Inc.

Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017, the 2022 divestiture of much of its local phone business in rural areas, and the 2026 sale of its remaining consumer fiber network to AT&T have shifted the company's operations away from the legacy consumer business and toward enterprise services, which account for about 85%-90% of revenue. Lumen offers businesses a full suite of communications services, providing colocation and data center services, data transportation, phone service, and internet access.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: